)
Zomedica (ZOM) investor relations material
Zomedica Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual Meeting scheduled for June 10, 2026, to be held virtually, with voting on director elections, auditor ratification, executive compensation, and a by-law amendment regarding adjourned meetings.
Shareholders of record as of April 21, 2026, are entitled to vote; each share carries one vote.
Proxy materials and annual reports are available online, and the company uses notice-and-access provisions for distribution.
Voting matters and shareholder proposals
Proposals include electing eight directors, ratifying Grant Thornton LLP as auditor for 2026, an advisory say-on-pay vote, and amending by-laws to limit adjourned meetings.
Board recommends voting FOR all proposals.
Shareholder proposals for the 2027 meeting must be submitted by December 29, 2026, and director nominations follow advance notice by-law procedures.
Board of directors and corporate governance
Board consists of eight members, majority independent, with diverse backgrounds in healthcare, law, and business.
Three standing committees: Audit, Compensation, and Nominating & Corporate Governance, all composed of independent directors.
Board met five times in 2025; all directors attended at least 75% of meetings.
Chairman and CEO roles are separated; Jeffrey Rowe is independent Chairman.
Code of Ethics, insider trading, anti-hedging, and clawback policies are in place.
- AI-driven digital platforms and recurring revenue growth position the company for profitability by 2027.ZOM
Status update13 Apr 2026 - Record revenue growth and strong margins, with new segments and cost controls driving performance.ZOM
Q4 202516 Mar 2026 - Profitability targeted for 2027, with strong R&D and product innovation fueling growth.ZOM
Status update27 Feb 2026 - Innovative veterinary solutions and recurring revenue drive high growth and margin expansion.ZOM
Small-Cap Growth Virtual Investor Conference1 Feb 2026 - Q2 revenue up 2% to $6.1M, but net loss surged on $16M impairment; margin reached 71%.ZOM
Q2 20241 Feb 2026 - Q3 revenue up 10% to $7M, 72% margin, net loss $6.7M, global expansion ongoing.ZOM
Q3 202415 Jan 2026 - Record $27.3M revenue, 70% margin, and strong liquidity set stage for 2025 growth.ZOM
Q4 202419 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and hold say-on-pay vote, with strong governance.ZOM
Proxy Filing2 Dec 2025 - Virtual annual meeting set for June 10; all shareholders urged to vote by June 8.ZOM
Proxy Filing2 Dec 2025
Next Zomedica earnings date
Next Zomedica earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage